牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

康辰药业（603590）

5.6

综合诊断：5.6分打败了84%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
有加速上涨趋势。
长期趋势：
已有46家主力机构披露2026-06-30报告期持股数据，持仓量总计3395.70万股，占流通A股21.46%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

6.6分

4.7分

5.5分

1.4分

6.9分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：6.6技术面打败了87%的股票技术面评分前10的股票

近期的平均成本为28.40元。多头行情中，并且有加速上涨趋势。

技术面得分最高的股票

平均成本

近期的平均成本为28.40元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"28.40","date":1789028647,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。

[{"date":"2026.09.11","stock":"-2.17","trade":"-2.86","ind":"-1.18"},{"date":"2026.09.10","stock":"-2.81","trade":"-2.43","ind":"-0.43"},{"date":"2026.09.09","stock":"-1.48","trade":"-1.46","ind":"0.28"},{"date":"2026.09.08","stock":"0.20","trade":"1.93","ind":"0.20"},{"date":"2026.09.07","stock":"0.80","trade":"0.09","ind":"0.07"},{"date":"2026.09.04","stock":"-0.40","trade":"-0.93","ind":"-0.30"},{"date":"2026.09.03","stock":"0.74","trade":"0.47","ind":"0.02"},{"date":"2026.09.02","stock":"-1.84","trade":"-1.26","ind":"-0.97"},{"date":"2026.09.01","stock":"0.96","trade":"0.61","ind":"-0.16"},{"date":"2026.08.31","stock":"-1.79","trade":"-2.01","ind":"0.86"},{"date":"2026.08.28","stock":"-2.32","trade":"-2.41","ind":"-0.11"},{"date":"2026.08.27","stock":"1.32","trade":"0.32","ind":"1.13"},{"date":"2026.08.26","stock":"0.71","trade":"0.94","ind":"0.59"},{"date":"2026.08.25","stock":"2.42","trade":"2.08","ind":"0.19"},{"date":"2026.08.24","stock":"-6.49","trade":"-4.47","ind":"-0.59"},{"date":"2026.08.21","stock":"-6.18","trade":"-3.50","ind":"0.04"},{"date":"2026.08.20","stock":"10.00","trade":"9.12","ind":"0.24"},{"date":"2026.08.19","stock":"-3.28","trade":"-2.79","ind":"-2.40"},{"date":"2026.08.18","stock":"-1.22","trade":"-1.53","ind":"0.19"},{"date":"2026.08.17","stock":"-0.18","trade":"0.14","ind":"1.41"},{"date":"2026.08.14","stock":"-1.12","trade":"0.21","ind":"0.01"}]

康辰药业,上证指数,生物制品指数

压力支撑

该股压力位为28.45元，支撑位为27.96元。

[{"text":"\u538b\u529b\u4f4d","value":"28.45","date":1789056000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"27.96","date":1789056000,"color":"0x0b52a1"}]

多空趋势

多头行情中，并且有加速上涨趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.7资金面打败了72%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：09月11日 20:32

机构今日流向(万元)	-2335.63	机构5日流向(万元)	-5743.98
机构10日流向(万元)	-12365.61	机构20日流向(万元)	-35303.25

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量减少1553.82万股，其中基金净增仓10家，主力净减仓107家，暂未发现中长期投资价值。

截止2026-06-30，共46家主力机构（基金40家，社保基金1家，基本养老保险基金2家，一般法人3家），持仓量总计3395.7万股，占流通A股21.46%
其中，基金持仓与2025-12-31相比：
增仓：14家，增持 20.25万股
减仓：4家，减持 76.08万股
新出现在主力名单中：22家，持有515.87万股
从主力名单中消失：129家，原持有2036.41万股

消息面诊股

诊断结果：5.5消息面打败了61%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	分红转增	不分配不转增	2026-08-26
一般消息	股东大会	临时股东大会	2026-07-04
一般消息	募资投向		2026-06-05
利好	分红转增	10派3.5元(含税)	2026-04-23
重大利好	业绩预告	业绩大幅上升	2026-01-08
一般消息	高管变动	取消监事会	2025-12-31

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	1条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：1.4行业面打败了14%的股票生物制品行业最新资金流向

近10日来该行业走势总体向下，明显跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势总体向下，明显跑输大盘。

[{"date":"2026.09.11","price":"-1.18","value":"-2.43"},{"date":"2026.09.10","price":"-0.43","value":"-1.46"},{"date":"2026.09.09","price":"0.28","value":"1.93"},{"date":"2026.09.08","price":"0.20","value":"0.09"},{"date":"2026.09.07","price":"0.07","value":"-0.93"},{"date":"2026.09.04","price":"-0.30","value":"0.47"},{"date":"2026.09.03","price":"0.02","value":"-1.26"},{"date":"2026.09.02","price":"-0.97","value":"0.61"},{"date":"2026.09.01","price":"-0.16","value":"-2.01"},{"date":"2026.08.31","price":"0.86","value":"-2.41"},{"date":"2026.08.28","price":"-0.11","value":"0.32"},{"date":"2026.08.27","price":"1.13","value":"0.94"},{"date":"2026.08.26","price":"0.59","value":"2.08"},{"date":"2026.08.25","price":"0.19","value":"-4.47"},{"date":"2026.08.24","price":"-0.59","value":"-3.50"},{"date":"2026.08.21","price":"0.04","value":"9.12"},{"date":"2026.08.20","price":"0.24","value":"-2.79"},{"date":"2026.08.19","price":"-2.40","value":"-1.53"},{"date":"2026.08.18","price":"0.19","value":"0.14"},{"date":"2026.08.17","price":"1.41","value":"0.21"},{"date":"2026.08.14","price":"0.01","value":"2.00"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	*ST未名	21.64%	-5.15%	5.3分
2	康希诺	12.45%	-8.17%	4.0分
3	金迪克	3.44%	3.69%	5.4分
4	赛伦生物	1.80%	-1.31%	4.8分
5	卫光生物	-0.10%	-7.43%	4.3分
6	康华生物	-0.37%	-4.48%	4.8分
7	上海莱士	-1.41%	-0.61%	5.1分
8	沃森生物	-1.43%	0.85%	5.0分
9	辽宁成大	-2.25%	-4.49%	4.6分
10	东宝生物	-2.76%	-3.14%	5.1分
11	智飞生物	-3.45%	-4.83%	4.6分
12	华兰生物	-3.54%	-1.84%	5.3分
13	天坛生物	-3.59%	-1.55%	5.4分
14	欧林生物	-4.31%	-3.26%	4.6分
15	-	-4.35%	-9.13%	分
16	成大生物	-4.84%	-2.89%	4.7分
17	华兰疫苗	-4.91%	0.53%	5.2分
18	博晖创新	-5.04%	-3.54%	5.0分
19	西藏药业	-5.26%	-1.97%	5.8分
20	百克生物	-6.51%	-6.69%	5.0分
21	康泰生物	-7.41%	-6.60%	4.4分
22	四环生物	-7.73%	-5.13%	5.1分
23	派林生物	-7.98%	-3.09%	5.0分
24	近岸蛋白	-8.02%	2.98%	4.2分
25	科兴制药	-9.27%	-6.69%	5.1分
26	博雅生物	-9.48%	-2.35%	5.0分
27	通化东宝	-9.57%	-3.37%	5.3分
28	优宁维	-9.85%	-3.85%	5.1分
29	禾元生物	-10.62%	-3.22%	6.0分
30	安科生物	-10.73%	-3.97%	5.5分
31	甘李药业	-11.52%	-5.36%	5.4分
32	荣昌生物	-12.41%	-7.66%	5.9分
33	百普赛斯	-12.76%	-3.68%	5.3分
34	康辰药业	-13.20%	-5.39%	5.6分
35	特宝生物	-14.39%	-8.62%	4.9分
36	双成药业	-14.69%	-3.09%	5.9分
37	万泽股份	-14.97%	-3.61%	5.6分
38	长春高新	-15.52%	-3.09%	5.1分
39	康弘药业	-16.07%	-6.35%	4.5分
40	智翔金泰	-16.96%	-5.85%	4.6分
41	诺诚健华	-17.51%	-16.97%	4.7分
42	-	-17.63%	2.53%	分
43	神州细胞	-17.74%	-6.14%	5.1分
44	赛升药业	-17.80%	-4.86%	4.7分
45	昊帆生物	-19.30%	-1.24%	5.1分
46	-	-19.35%	-10.69%	分
47	三生国健	-21.34%	-9.70%	5.5分
48	诺唯赞	-21.91%	0.00%	5.7分
49	君实生物	-21.94%	-7.02%	5.7分
50	艾迪药业	-22.15%	-8.48%	5.3分
51	泰诺麦博	-25.60%	-12.72%	4.5分
52	百奥泰	-25.78%	-7.09%	5.0分
53	我武生物	-26.63%	-13.57%	4.3分
54	义翘神州	-28.89%	0.66%	4.8分
55	迈威生物	-29.24%	-12.25%	4.6分

<上一页 1 2 3 4 5...10 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.9基本面打败了89%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：中（87.5分）

基本面得分最高的股票

[ 截止日期：2026-06-30 ]公司经营

盈利能力：很强，居行业前列，两项指标的行业排名分别为 18/73 ， 8/73。

[{"date":"2026-06-30","value":"2.99","vol":"-8.07"},{"date":"2026-03-31","value":"1.47","vol":"-6.34"},{"date":"2025-12-31","value":"5.22","vol":"-12.02"},{"date":"2025-09-30","value":"4.03","vol":"-9.89"},{"date":"2025-06-30","value":"2.91","vol":"-3.57"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净资产收益率(%)	2.99	1.47	5.22	4.03	2.91
行业(%)	-8.07	-6.34	-12.02	-9.89	-3.57

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"89.81","vol":"55.74"},{"date":"2026-03-31","value":"89.81","vol":"60.27"},{"date":"2025-12-31","value":"89.92","vol":"65.27"},{"date":"2025-09-30","value":"90.15","vol":"66.41"},{"date":"2025-06-30","value":"90.18","vol":"66.14"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
销售毛利率(%)	89.81	89.81	89.92	90.15	90.18
行业(%)	55.74	60.27	65.27	66.41	66.14

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 29/73 ， 28/73。

[{"date":"2026-06-30","value":"0.42","vol":"31.09"},{"date":"2026-03-31","value":"1.35","vol":"291.45"},{"date":"2025-12-31","value":"10.87","vol":"39.10"},{"date":"2025-09-30","value":"7.10","vol":"44.93"},{"date":"2025-06-30","value":"13.79","vol":"6771.91"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
营业收入同比增长率(%)	0.42	1.35	10.87	7.10	13.79
行业(%)	31.09	291.45	39.10	44.93	6771.91

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"5.14","vol":"18.81"},{"date":"2026-03-31","value":"6.10","vol":"71.92"},{"date":"2025-12-31","value":"293.13","vol":"36.03"},{"date":"2025-09-30","value":"13.19","vol":"44.79"},{"date":"2025-06-30","value":"14.95","vol":"5.12"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净利润同比增长率(%)	5.14	6.10	293.13	13.19	14.95
行业(%)	18.81	71.92	36.03	44.79	5.12

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，两项指标的行业排名分别为 28/73 ， 8/73。

[{"date":"2026-06-30","value":"0.11","vol":"0.14"},{"date":"2026-03-31","value":"0.05","vol":"0.06"},{"date":"2025-12-31","value":"0.23","vol":"0.30"},{"date":"2025-09-30","value":"0.17","vol":"0.21"},{"date":"2025-06-30","value":"0.12","vol":"0.13"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
总资产周转率(次)	0.11	0.05	0.23	0.17	0.12
行业(次)	0.14	0.06	0.30	0.21	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.85","vol":"0.63"},{"date":"2026-03-31","value":"0.39","vol":"0.28"},{"date":"2025-12-31","value":"1.45","vol":"1.26"},{"date":"2025-09-30","value":"1.04","vol":"0.88"},{"date":"2025-06-30","value":"0.64","vol":"0.54"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
存货增长率(次)	0.85	0.39	1.45	1.04	0.64
行业(次)	0.63	0.28	1.26	0.88	0.54

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：较强，高于行业平均，两项指标的行业排名分别为 39/73 ， 31/73。

[{"date":"2026-06-30","value":"-6.47","vol":"-1291.20"},{"date":"2026-03-31","value":"9.59","vol":"-144.81"},{"date":"2025-12-31","value":"14.26","vol":"12.60"},{"date":"2025-09-30","value":"41.31","vol":"0.21"},{"date":"2025-06-30","value":"7.97","vol":"-1377.57"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
现金流量净额/营业收入	-6.47	9.59	14.26	41.31	7.97
行业	-1291.20	-144.81	12.60	0.21	-1377.57

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"1.26","vol":"1.53"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.47","vol":"1.73"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.63","vol":"1.53"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资本支出／折旧和摊销	1.26	-	1.47	-	1.63
行业	1.53	0.00	1.73	0.00	1.53

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 7/73 ， 23/73。

[{"date":"2026-06-30","value":"2.55","vol":"5.55"},{"date":"2026-03-31","value":"3.05","vol":"6.58"},{"date":"2025-12-31","value":"3.04","vol":"5.74"},{"date":"2025-09-30","value":"3.12","vol":"5.95"},{"date":"2025-06-30","value":"4.13","vol":"6.47"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
流动比率	2.55	3.05	3.04	3.12	4.13
行业	5.55	6.58	5.74	5.95	6.47

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"2.21","vol":"4.13"},{"date":"2026-03-31","value":"2.62","vol":"5.09"},{"date":"2025-12-31","value":"2.58","vol":"4.39"},{"date":"2025-09-30","value":"2.65","vol":"4.79"},{"date":"2025-06-30","value":"3.42","vol":"5.16"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
速动比率	2.21	2.62	2.58	2.65	3.42
行业	4.13	5.09	4.39	4.79	5.16

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 31/73 ， 31/73。

[{"date":"2026-06-30","value":"15.68","vol":"30.05"},{"date":"2026-03-31","value":"13.97","vol":"29.49"},{"date":"2025-12-31","value":"14.62","vol":"29.33"},{"date":"2025-09-30","value":"13.92","vol":"27.48"},{"date":"2025-06-30","value":"12.04","vol":"27.37"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资产负债率(%)	15.68	13.97	14.62	13.92	12.04
行业(%)	30.05	29.49	29.33	27.48	27.37

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.20","vol":"1.38"},{"date":"2026-03-31","value":"0.18","vol":"2.52"},{"date":"2025-12-31","value":"0.19","vol":"1.42"},{"date":"2025-09-30","value":"0.18","vol":"0.57"},{"date":"2025-06-30","value":"0.15","vol":"1.24"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
产权比率 (%)	0.20	0.18	0.19	0.18	0.15
行业(%)	1.38	2.52	1.42	0.57	1.24

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
首创证券	2026-09-08	买入
中泰证券	2026-09-02	买入
中航证券	2026-09-02	买入
太平洋	2026-09-02	买入
国海证券	2026-08-26	增持
东北证券	2026-08-25	增持

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"1.01","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.50","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.42","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.66","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"1.83","blueLineValue":"1.16","type":"YC"}]

[康辰药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]